MedPath

Effect of liverpower on liver function in fatty liver

Phase 3
Recruiting
Conditions
Fatty liver.
Fatty (change of) liver, not elsewhere classified
K76.0
Registration Number
IRCT20140804018677N11
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Liver function enzymes higher than normal level
Fatty liver diagnosis based on sonography
Age>18 years
Willing to participate in the study

Exclusion Criteria

Having known kidney disease
Having known heart disease
Pregnancy or lactation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Alanine Aminotransferase (ALT) enzyme. Timepoint: Baseline and at the end of the study. Method of measurement: Biochemical kits.;Aspartate transaminase (AST) enzyme. Timepoint: Baseline and at the end of the study. Method of measurement: Biochemical kits.;Alkaline phosphatase (Alk-ph) enzyme. Timepoint: Baseline and at the end of the study. Method of measurement: Biochemical kits.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath